Estrogenic tamoxifen derivatives: Categorization of intrinsic estrogenicity in MCF-7 cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 63, Issue 4-6, 1997, Pages 203-209

  Ruenitz, Peter C ^a   Moore, Susan A ^a   Kraft, Kelly S ^a   Bourne, Caryl S ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [1 (4 HYDROXYPHENYL) 2 PHENYL 1 BUTENYL]PHENOXYACETIC ACID; CARBOXYLIC ACID DERIVATIVE; CHLOROTRIANISENE; ESTRADIOL; ESTROGEN RECEPTOR; TAMOXIFEN DERIVATIVE; TRIARYLETHYLENE OXYACETIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL GROWTH; CELL STIMULATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LIGAND BINDING; RECEPTOR BINDING;

BREAST NEOPLASMS; CELL DIVISION; CELL LINE; ESTROGENS; MOLECULAR MIMICRY; PROTEIN BINDING; RECEPTORS, ESTROGEN; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0031413488     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00118-0     Document Type: Article

References (20)

1. Ruenitz PC, Female sex hormones and analogs. In Burger's Medicinal Chemistry, 5th edn, ed. ME Wolff. Wiley, New York. (1997) Vol. 4, ch. 57.
2. Ruenitz P. C. and Nanavati N. T., Identification and distribution in the rat of acidic metabolites of tamoxifen. Drug Metab. Dispos. 18 (1990) 645-648.
3. Sato M., Rippy M. K. and Bryant H. U., Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB J. 10 (1996) 905-912.
4. Wilson S., Ruenitz P. C. and Ruzicka J. A., Estrogen receptor affinity and effects on MCF-7 cell growth of triarylethylene carboxylic acids related to tamoxifen. J. Steroid Biochem. Molec. Biol. 42 (1992) 613-616.
5. Ruenitz P. C., Bourne C. S., Sullivan K. J. and Moore S. A., Estrogenic triarylethylene acetic acids: effect of structural variation on estrogen receptor affinity and estrogenic potency and efficacy in MCF-7 cells. J. Med. Chem. 39 (1996) 4853-4859.
6. Jones C. D., Blaszczak L. C., Goettel M. E., Suarez T., Crowell T. A., Mabry T. E., Ruenitz P. C. and Srivatsan V., Antiestrogens. 3. Estrogen receptor affinities and antiproliferative effects of phenolic analogues of trioxifene, [3,4-dihydro-2-(4-methoxyphenyl)-1-naphthalenyl] [4-[2-(1-pyrrolidinyl)ethoxy]phenyl]methanone. J. Med. Chem. 35 (1992) 931-938.
7. i and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108.
8. Butler W. B., Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle. Anal. Biochem. 141 (1984) 70-73.
9. Bignon E., Pons M., de Faulet Crastes A., Doré J-C., Gilbert J., Abecassis J., Miquel J-F., Ojasoo T. and Raynaud J-P., Effect of triphenylacrylonitrile derivatives on estradiol-receptor binding and on human breast cancer cell growth. J. Med. Chem. 32 (1989) 2092-2103.
10. Soto A. M., Sonnenschein C., Chung K. L., Fernandez M. F., Olea N. and Serrano F. O., The E-screen assay as a tool to identify estrogens - an update on estrogenic environmental pollutants. Environ. Health Perspectives 103 (1995) 113-122.
11. Murphy C. S., Langan-Fahey S. M., McCague R. and Jordan V. C., Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro. Mol. Pharmacol. 38 (1990) 737-743.
12. 5 adrenal steroids. Endocrinology (Baltimore) 127 (1990) 2757-2762.
13. Kohno H., Gandini O., Curtis S. W. and Korach K. S., Anti-estrogen activity in the yeast transcription system: estrogen receptor mediated agonist response. Steroids 59 (1994) 572-578.
14. Hyder S. M., Shipley G. L. and Stancel G. M., Estrogen action in target cells: selective requirements for activation of different hormone response elements. Mol. Cell. Endocrinol. 112 (1995) 35-43.
15. Stoessel S. and Leclercq G., Competitive binding assay for estrogen receptor in monolayer culture: measure of receptor activation potency. J. Steroid Biochem. 25 (1986) 677-682.
16. Gyling M. and Leclercq G., Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells-relationship between processing and estrogenicity. J. Steroid Biochem. 29 (1988) 1-8.
17. Katzenellenbogen J. A., O'Malley B. and Katzenellenbogen B. S., Tripartite steroid hormone pharmacology: interaction with multiple effector sites as a basis for the cell-and promoter-specific action of these hormones. Mol. Endocrinol. 10 (1996) 119-131.
18. Willson T. M., Henke B. R., Momtahen T. M., Charifson P. S., Batchelor K. W., Lubahn D. B., Moore L. B., Oliver B. B., Sauls H. R., Triantafillou J. A., Wolfe S. G. and Baer P. G., 3-[4-(l,2-diphenylbut-l-enyl)phenyl]acrylic acid: a non-steroidal estrogen with functional selectivity for bone over uterus in rats. J. Med. Chem. 37 (1994) 1550-1552.
19. Magarian R. A., Overacre L. B., Singh S. and Meyer K. L., The medicinal chemistry of nonsteroidal antiestrogens: a review. Curr. Med. Chem. 1 (1994) 61-104.
20. Shen Y, Li M, Liang H, Whitehead D, Wronski TJ, and Ruenitz PC, Bone protective effects of nonsteroidal estrogen receptor (ER) ligands in ovariectomized rats. J. Bone Miner. Res. 12 (1997) 5354.